Study of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections, Icluding COVID-19
Clinical trial NCT05054114 · COMPLETED
Trial details
- NCT number
- NCT05054114
- Sponsor
- SPP Pharmaclon Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-21
- Primary completion
- 2021-05-25
- Enrollment
- 630
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.